Garry Meakin

455 total citations
16 papers, 115 citations indexed

About

Garry Meakin is a scholar working on Physiology, Public Health, Environmental and Occupational Health and General Health Professions. According to data from OpenAlex, Garry Meakin has authored 16 papers receiving a total of 115 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Physiology, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in General Health Professions. Recurrent topics in Garry Meakin's work include Reproductive tract infections research (3 papers), Ethics in Clinical Research (3 papers) and Asthma and respiratory diseases (3 papers). Garry Meakin is often cited by papers focused on Reproductive tract infections research (3 papers), Ethics in Clinical Research (3 papers) and Asthma and respiratory diseases (3 papers). Garry Meakin collaborates with scholars based in United Kingdom and Ireland. Garry Meakin's co-authors include Dominick Shaw, Helen D. Bailey, John R. Anderson, David Hodgson, Catherine Reynolds, Lelia Duley, Tim Harrison, Kevin Mortimer, Clare Brittain and Janet Oborne and has published in prestigious journals such as CHEST Journal, Thorax and BMJ Open.

In The Last Decade

Garry Meakin

16 papers receiving 114 citations

Peers

Garry Meakin

PHYSI

PRM

MICRO

PHEOH

EPIDE

Markus Schnappinger Germany

Damian Korzybski Poland

Peter J. Wills United Kingdom

M. E. Soto‐Quiros Costa Rica

SS Birring United Kingdom

Karl Holden United Kingdom

Gabriele Nagel Germany

R. Pawankar Italy

Yanmei Ju China

Heena Mistry United Kingdom

Markus Schnappinger Germany

Garry Meakin

88 ×1.5

PHYSI

18 ×0.3

PRM

0 ×0.0

MICRO

15 ×1.0

PHEOH

15 ×1.2

EPIDE

Citations per year, relative to Garry Meakin Garry Meakin (= 1×) peers Markus Schnappinger

Countries citing papers authored by Garry Meakin

Since Specialization

Citations

This map shows the geographic impact of Garry Meakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Meakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Meakin more than expected).

Fields of papers citing papers by Garry Meakin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Meakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Meakin. The network helps show where Garry Meakin may publish in the future.

Co-authorship network of co-authors of Garry Meakin

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Meakin. A scholar is included among the top collaborators of Garry Meakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Meakin. Garry Meakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mitchell, Eleanor, Garry Meakin, Jon Dorling, et al.. (2022). The FEED1 trial: protocol for a randomised controlled trial of full milk feeds versus intravenous fluids with gradual feeding for preterm infants (30–33 weeks gestational age). Trials. 23(1). 64–64. 8 indexed citations

Leighton, Paul, Joanne R Chalmers, Jonathan Batchelor, et al.. (2022). Prescribing and using vitiligo treatments: lessons from a nested process evaluation within the HI-Light vitiligo randomized controlled trial. Clinical and Experimental Dermatology. 47(8). 1480–1489. 1 indexed citations

Love, Sharon, Elizabeth C. Ward, Katie Keen, et al.. (2022). What is the purpose of clinical trial monitoring?. Trials. 23(1). 836–836. 5 indexed citations

Haines, Rachel, Garry Meakin, Wei Tan, et al.. (2020). Protocol for a multi-centre randomised controlled stand-alone feasibility trial to assess potential effectiveness and cost-effectiveness of digital hearing aids in patients with tinnitus and hearing loss (the HUSH trial). Pilot and Feasibility Studies. 6(1). 41–41. 4 indexed citations

Mitchell, Eleanor, Peter J. Godolphin, Garry Meakin, & Kirsty Sprange. (2020). Do investigator meetings improve recruitment rates in clinical trials? A retrospective before-and-after study of data from nine multi-centre clinical trials. Trials. 21(1). 514–514. 4 indexed citations

Ross, Jonathan, J. W. Harding, Lelia Duley, et al.. (2019). Gentamicin as an alternative to ceftriaxone in the treatment of gonorrhoea: the G-TOG non-inferiority RCT. Health Technology Assessment. 23(20). 1–104. 2 indexed citations

Haines, Rachel, Kim S Thomas, Alan Montgomery, et al.. (2018). Home interventions and light therapy for the treatment of vitiligo (HI-Light Vitiligo Trial): study protocol for a randomised controlled trial. BMJ Open. 8(4). e018649–e018649. 5 indexed citations

Lim, Wei Shen, Garry Meakin, Clare Brittain, Thomas Bewick, & Lelia Duley. (2017). Improving readiness for recruitment through simulated trial activation: the Adjuvant Steroids in Adults with Pandemic influenza (ASAP) trial. Trials. 18(1). 546–546. 3 indexed citations

Ross, Jonathan, J. W. Harding, Lelia Duley, et al.. (2017). LB1.5 The efficacy and safety of gentamicin for the treatment of genital, pharyngeal and rectal gonorrhoea: a randomised controlled trial. HighWire Press Open Archive. A42.2–A43. 9 indexed citations

10.

Brittain, Clare, Margaret Childs, Lelia Duley, et al.. (2016). Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial. Trials. 17(1). 558–558. 9 indexed citations

11.

Hodgson, David, John R. Anderson, Catherine Reynolds, et al.. (2016). The Effects of Azithromycin in Treatment-Resistant Cough. CHEST Journal. 149(4). 1052–1060. 37 indexed citations

12.

Hodgson, David, John R. Anderson, Catherine Reynolds, et al.. (2015). A randomised controlled trial of small particle inhaled steroids in refractory eosinophilic asthma (SPIRA). Thorax. 70(6). 559–565. 13 indexed citations

13.

Brittain, Clare, et al.. (2015). Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks. Trials. 16(S2). 9 indexed citations

14.

John, M. Knight, Alan J. Knox, Garry Meakin, et al.. (2013). S27 The effects of statin therapy on inflammatory markers in patients with copd: a double blind randomised controlled trial. Thorax. 68(Suppl 3). A16.3–A17. 1 indexed citations

15.

Saini, Gauri, Gísli Jenkins, Tricia M. McKeever, et al.. (2012). The PROFILE Study: A Prospective Study Of Fibrosis In Lung Endpoints To Discover And Qualify Biomarkers For Use In Clinical Trials. A5169–A5169. 4 indexed citations

16.

Hodgson, David, John R. Anderson, Emma Wilson, et al.. (2012). Neutrophilic Airway Inflammation And Response To Prednisolone In Patients With Refractory Eosinophilic Asthma. A4227–A4227. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact